• Home
  • Search
  • Sputum processing for evaluation of inflammatory mediators.
  • Cite Icon47
  • https://doi.org/10.1002/ppul.1101Copy DOI Icon

Sputum processing for evaluation of inflammatory mediators.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Sputum processing for evaluation of inflammatory mediators.

Similar Papers
  • Front Matter
  • Citations3

Dornase Alfa Therapy in Cystic Fibrosis: Who Should Get It?

  • Oct 01, 1996
  • Chest
  • Jamshed F Kanga
  • Research Article
  • Citations168

Dornase alfa for cystic fibrosis.

  • Apr 04, 2016
  • The Cochrane database of systematic reviews
  • Connie Yang +3
  • Research Article
  • Citations22

Thymosin β4 Sequesters Actin in Cystic Fibrosis Sputum and Decreases Sputum Cohesivity in Vitro

  • Nov 01, 2006
  • Chest
  • Bruce K Rubin +2
  • Research Article
  • Citations1

Clinical and functional control of mucolytic therapy in children with cystic fibrosis

  • Apr 06, 2022
  • Meditsinskiy sovet = Medical Council
  • O I Simonova +2
  • Research Article
  • Citations18

Dornase Alfa

  • Sep 01, 1997
  • PharmacoEconomics
  • Karen L Goa +1
  • Research Article
  • Citations3

Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.

  • Dec 02, 2020
  • American Journal of Respiratory Cell and Molecular Biology
  • Apparao B Kummarapurugu +7
  • Research Article
  • Citations105

Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum

  • Jan 10, 2007
  • European Respiratory Journal
  • R Bucki +2
  • Research Article
  • Citations324

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

  • Dec 01, 2001
  • The Journal of Pediatrics
  • Joanne M Quan +7
  • Abstract

PND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis

  • Oct 27, 2011
  • Value in Health
  • D.J Pasta +2
  • Research Article
  • Citations26

Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis

  • Jun 01, 1999
  • The Journal of Pediatrics
  • Charles A Johnson +4
  • Research Article
  • Citations6

The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators

  • Sep 01, 2024
  • Expert Review of Respiratory Medicine
  • Erica A Roesch +3
  • Research Article

Possibilities of using recombinant human deoxyribonuclease I in otorhinolaryngology

  • May 15, 2023
  • Russian Bulletin of Otorhinolaryngology
  • K.V Eremeeva +4
  • Research Article
  • Citations211

Myeloperoxidase and protein oxidation in cystic fibrosis.

  • Sep 01, 2000
  • American Journal of Physiology-Lung Cellular and Molecular Physiology
  • Albert Van Der Vliet +5
  • Research Article
  • Citations25

Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis

  • Aug 28, 2007
  • Pediatric Pulmonology
  • S.G Mckenzie +3
  • Research Article
  • Citations7

Comparison of susceptibility of cystic-fibrosis-related and non-cystic-fibrosis-related Pseudomonas aeruginosa to chlorine-based disinfecting solutions: implications for infection prevention and ward disinfection.

  • Jun 12, 2014
  • Journal of medical microbiology
  • John E Moore +1
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.